SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: LoLoLoLita who wrote (3460)4/20/1998 8:19:00 AM
From: F. Jay Abella, III  Read Replies (1) | Respond to of 7041
 
Dauntless (Ggeorges):

I have a surprise for you today (maybe tomorrow) at my site

S-3 filings, if registered by certain selling shareholders, don't result in proceeds to the company. The registry allows a mechanism by which ownership may be transferred from one party to another. The stocks that have this happen usually decline in price in the interim, and sometimes blow-up within a year (ALTN, CTII, LIPO, etc).

I will publish about 20 such cases. Amazingly all of these were taken from Buyside magazine, many of which have "buy" recommendations from analysts. The houses include - H&Q, Volpe Brown, BankAmerica RS, CIBC, Nationsbank Montgomery, etc.

The analyst and his retail staff get a commission on every single transmission of ownership in which they participate. In cases where a one-thousand-share-at-a-time distribution takes place, I find a lively discussion at SI. Amazing.

FJA

I am not saying that something like this will happen with ZONA. Simply watch for it.